載入...
Persistent bone marrow depression following short-term treatment with temozolomide
Temozolomide (TMZ) is, in combination with radiotherapy (RT), the treatment of choice for glioblastoma multiforme. Although generally well tolerated, haematological side effects are observed in approximately 1–10% of patients receiving TMZ. We report a case of a patient who developed severe bone mar...
Na minha lista:
| 發表在: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4854153/ https://ncbi.nlm.nih.gov/pubmed/27130558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-215797 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|